These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37302654)

  • 1. Patient-Induced Pluripotent Stem Cell-Derived Hepatostellate Organoids Establish a Basis for Liver Pathologies in Telomeropathies.
    Choi YJ; Kim MS; Rhoades JH; Johnson NM; Berry CT; Root S; Chen Q; Tian Y; Fernandez RJ; Cramer Z; Adams-Tzivelekidis S; Li N; Johnson FB; Lengner CJ
    Cell Mol Gastroenterol Hepatol; 2023; 16(3):451-472. PubMed ID: 37302654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells.
    Donaires FS; Alves-Paiva RM; Gutierrez-Rodrigues F; da Silva FB; Tellechea MF; Moreira LF; Santana BA; Traina F; Dunbar CE; Winkler T; Calado RT
    Stem Cell Res; 2019 Oct; 40():101540. PubMed ID: 31479877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients.
    Gu BW; Apicella M; Mills J; Fan JM; Reeves DA; French D; Podsakoff GM; Bessler M; Mason PJ
    PLoS One; 2015; 10(5):e0127414. PubMed ID: 25992652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing a Wnt-Telomere Feedback Loop Restores Intestinal Stem Cell Function in a Human Organotypic Model of Dyskeratosis Congenita.
    Woo DH; Chen Q; Yang TL; Glineburg MR; Hoge C; Leu NA; Johnson FB; Lengner CJ
    Cell Stem Cell; 2016 Sep; 19(3):397-405. PubMed ID: 27545506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.
    Batista LF; Pech MF; Zhong FL; Nguyen HN; Xie KT; Zaug AJ; Crary SM; Choi J; Sebastiano V; Cherry A; Giri N; Wernig M; Alter BP; Cech TR; Savage SA; Reijo Pera RA; Artandi SE
    Nature; 2011 May; 474(7351):399-402. PubMed ID: 21602826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function.
    Lai FP; Lau ST; Wong JK; Gui H; Wang RX; Zhou T; Lai WH; Tse HF; Tam PK; Garcia-Barcelo MM; Ngan ES
    Gastroenterology; 2017 Jul; 153(1):139-153.e8. PubMed ID: 28342760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of dyskeratosis congenita-like hematopoietic stem cells through the stable inhibition of DKC1.
    Carrascoso-Rubio C; Zittersteijn HA; Pintado-Berninches L; Fernández-Varas B; Lozano ML; Manguan-Garcia C; Sastre L; Bueren JA; Perona R; Guenechea G
    Stem Cell Res Ther; 2021 Jan; 12(1):92. PubMed ID: 33514435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effects of carboxymethyl-hexanoyl chitosan, cationic polyurethane-short branch PEI in miR122 gene delivery: accelerated differentiation of iPSCs into mature hepatocyte-like cells and improved stem cell therapy in a hepatic failure model.
    Chien Y; Chang YL; Li HY; Larsson M; Wu WW; Chien CS; Wang CY; Chu PY; Chen KH; Lo WL; Chiou SH; Lan YT; Huo TI; Lee SD; Huang PI
    Acta Biomater; 2015 Feb; 13():228-44. PubMed ID: 25463491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated hematopoietic stem cell aging in a mouse model of dyskeratosis congenita responds to antioxidant treatment.
    Gu BW; Fan JM; Bessler M; Mason PJ
    Aging Cell; 2011 Apr; 10(2):338-48. PubMed ID: 21241452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
    Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
    J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report.
    Ratnasamy V; Navaneethakrishnan S; Sirisena ND; Grüning NM; Brandau O; Thirunavukarasu K; Dagnall CL; McReynolds LJ; Savage SA; Dissanayake VHW
    BMC Med Genet; 2018 May; 19(1):85. PubMed ID: 29801475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral organoids derived from Sandhoff disease-induced pluripotent stem cells exhibit impaired neurodifferentiation.
    Allende ML; Cook EK; Larman BC; Nugent A; Brady JM; Golebiowski D; Sena-Esteves M; Tifft CJ; Proia RL
    J Lipid Res; 2018 Mar; 59(3):550-563. PubMed ID: 29358305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-targeted genome editing of human induced pluripotent stem cell-derived hepatocytes for the treatment of Wilson's disease.
    Wei R; Yang J; Cheng CW; Ho WI; Li N; Hu Y; Hong X; Fu J; Yang B; Liu Y; Jiang L; Lai WH; Au KW; Tsang WL; Tse YL; Ng KM; Esteban MA; Tse HF
    JHEP Rep; 2022 Jan; 4(1):100389. PubMed ID: 34877514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-iPSC-Derived Kidney Organoids Show Functional Validation of a Ciliopathic Renal Phenotype and Reveal Underlying Pathogenetic Mechanisms.
    Forbes TA; Howden SE; Lawlor K; Phipson B; Maksimovic J; Hale L; Wilson S; Quinlan C; Ho G; Holman K; Bennetts B; Crawford J; Trnka P; Oshlack A; Patel C; Mallett A; Simons C; Little MH
    Am J Hum Genet; 2018 May; 102(5):816-831. PubMed ID: 29706353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Combined Model of Human iPSC-Derived Liver Organoids and Hepatocytes Reveals Ferroptosis in DGUOK Mutant mtDNA Depletion Syndrome.
    Guo J; Duan L; He X; Li S; Wu Y; Xiang G; Bao F; Yang L; Shi H; Gao M; Zheng L; Hu H; Liu X
    Adv Sci (Weinh); 2021 May; 8(10):2004680. PubMed ID: 34026460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere phenotypes in females with heterozygous mutations in the dyskeratosis congenita 1 (DKC1) gene.
    Alder JK; Parry EM; Yegnasubramanian S; Wagner CL; Lieblich LM; Auerbach R; Auerbach AD; Wheelan SJ; Armanios M
    Hum Mutat; 2013 Nov; 34(11):1481-5. PubMed ID: 23946118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
    Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
    Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity of X-linked dyskeratosis congenita (DKCX) cellular defects is not directly related to dyskerin (DKC1) activity in ribosomal RNA biogenesis or mRNA translation.
    Thumati NR; Zeng XL; Au HH; Jang CJ; Jan E; Wong JM
    Hum Mutat; 2013 Dec; 34(12):1698-707. PubMed ID: 24115260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paracrine signals regulate human liver organoid maturation from induced pluripotent stem cells.
    Asai A; Aihara E; Watson C; Mourya R; Mizuochi T; Shivakumar P; Phelan K; Mayhew C; Helmrath M; Takebe T; Wells J; Bezerra JA
    Development; 2017 Mar; 144(6):1056-1064. PubMed ID: 28275009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
    Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
    J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.